Yong Zang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Combination Therapy

Top Venues

Statistical methods in medical research

Pharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Mu Shan, Beibei Guo, Hao Liu, Qian Li, Yong Zang
Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effect. Statistical methods in medical research (2023)
Jina Park, Wenjing Hu, Ick Hoon Jin, Hao Liu, Yong Zang
A Bayesian adaptive biomarker stratified phase II randomized clinical trial design for radiotherapies with competing risk survival outcomes. Statistical methods in medical research (2023)
Beibei Guo, Yong Zang
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapy. Statistical methods in medical research 31 (6) (2022)
Yifei Zhang, Beibei Guo, Sha Cao, Chi Zhang, Yong Zang
SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trials. Pharmaceutical statistics 21 (5) (2022)
Yifei Zhang, Yong Zang
CWL: A conditional weighted likelihood method to account for the delayed joint toxicity-efficacy outcomes for phase I/II clinical trials. Statistical methods in medical research 30 (3) (2020)